🔗 Share this article

A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could result in users injecting products of unknown origin.

Some experts said the demand for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Reaction and Material Elimination

According to the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The organization said it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Online Trading Operations

Research also found communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, populated with photos of slimming results, positive reviews and detailed instructions for mixing or administering at home.

Within moments of joining one group, a vendor shared contact information, where the majority of transactions take place. The vendor sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or previous experience.

Item Information and Costs

Inside these communities, posts show black plastic packages with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially serious health risks”.